Osteoarthritis (OA) is one of the leading causes of dis ability worldwide 1 . With the average age of the general population increasing, the impact of OA and joint pain is set to rise 2 . Disabling hand pain is a common complaint, affecting ~12% of individuals aged over 50 years in the UK general population 3 . For many of these individuals, this symptom can be ascribed to hand OA, which is the most common form of OA. Hand OA is a hetero geneous condition, often involving multiple joints 4 , and can have distinct (but sometimes overlapping) patterns of joint involvement: for example, OA of the inter phalangeal joints (IPJs) and/or the first carpometacarpal joint (CMCJ) 5 . A gap exists between guidelines for the manage ment of hand OA and current standards of treatment 6 . Healthcare inititatives such as JIGSAWE (Joint Implementation of Guidelines for Osteoarthritis in Western Europe; funded by EITHealth) aim to close the evidence-practice gap for OA 7 by implementing inter national guidelines and quality standards 8, 9 . A common misconception is that OA of the hands affects the quality of life of individuals less than OA of the lower limbs, and many patients are encouraged to believe that hand OA is an inevitable result of ageing and that nothing can be done to improve the disease symptoms 10 . These unfounded assumptions make prioritizing health care for hand OA a challenge.
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In this Review, we provide an overview of the epi demiology, presentation and burden of hand OA and present areas where in the past 5 years new evidence has substantially changed the way we understand, consider and treat hand OA. We include updates on the imaging of hand OA and the development of novel imaging techniques, and advances in knowledge of disease mechanisms and the management of hand OA.
Epidemiology

Definitions of hand OA
Hand OA can be defined in a number of ways: by the ACR clinical criteria 11 ; by structural changes deter mined by imaging (most frequently using plain radi ography; socalled radiographic hand OA); and by radiographic changes accompanied by the presence of typical symptoms (pain, aching or stiffness; referred to as symptomatic hand OA). For the latter two catego ries, a range of different definitions, particularly radio graphic definitions 12 , has been used in the study of hand OA (Box 1).
Radiographically, hand OA is characterized, as with other forms of OA, by joint space narrowing (JSN), osteophyte formation (which, for any joint, is patho gnomonic of radiographic OA), subchondral sclerosis and subchondral cyst formation. Researchers have attempted to improve the detection of early disease fea tures (including features that might not be evident by plain radiograph) by using MRI or ultrasonography; however, these techniques have not found a place in the diagnosis of hand OA in the clinic to date 13 . 
Prevalence
Hand OA is a highly prevalent condition with a well recognized female preponderance that is particularly notable in patients with severe symptomatic disease presenting to secondary care 14, 15 . Estimates of the prev alence of hand OA vary depending on the definition of hand OA used, as well as by the age, sex and geo graphical area of the population studied, and can also be influenced by genetic factors, occupation and diet. Of the various hand OA definitions, radiographic hand OA is associated with the highest prevalence, ranging from 21% in a US population to 92% in a Japanese popu lation [16] [17] [18] . By contrast, the prevalence of symp tomatic hand OA is much lower than radiographic hand OA, ranging from 3% in Iranian and Chinese populations to 16% in a US population [19] [20] [21] . Prevalence estimates for hand OA are generally higher than those reported for hip and knee OA (hip OA: radiographic 1.0-45.0% and symptomatic 0.9-7.4%; knee OA: radio graphic 7.1-70.8% and symptomatic 5.4-24.2%) 16 . The prevalence of hand OA is also higher in some groups of individuals, such as in patients with an HIV1 infection, than in the general population 22 .
Incidence and progression
The distinction between incidence (occurrence of the disease) and progression (development towards a more advanced stage of the disease) of hand OA is somewhat arbitrary and depends on the case defi nition of the disease used. With this caveat in mind, in one study of a US population, the lifetime risk of developing symptomatic hand OA in at least one hand by the age of 85 years was estimated at 40%, with 47% of women and 25% of men developing the disease in this population 23 . The annual incidence of hand OA varies between 0.2% and 4.7% for radio graphic hand OA and between 0.1% and 1.1% for symptomatic hand OA irrespective of age, sex and geographical location [24] [25] [26] (TaBle 1) . The incidence of hand OA peaks at the age of 50 in women and greatly exceeds the incidence measured for men at that age 27 . Progression of hand OA is usually slow, and only few hand joints exhibit changes in each patient 25 . The rates of radiographic progression vary from 3.2% to 23 .5% per year depending on the population studied, the grading scale used and whether the definition of progression also incorporates incident OA (that is, newonset OA) 24, 28 (TaBle 2) .
Disease presentation and burden
Signs and symptoms OA is considered a condition of the whole joint, rather than just the articular cartilage, and signs and symp toms can arise from the cartilage, underlying bone, syn ovium, muscles, tendons and ligaments (or the sites of ligament insertion into the bone) 29, 30 . Symptoms com monly include pain, stiffness and limitation or restric tion of movement such as a decrease of grip and/or pinch strength. Signs of hand OA include 'nodes' of the affected IPJs (firm swellings over the superolateral and dorsal aspects of the distal interphalangeal joints (DIPJs) and proximal interphalangeal joints (PIPJs), known as Heberden and Bouchard nodes, respectively) and deformities such as squaring of the thumb base (Fig. 1) . Inflammation can produce redness, warmth, effusion and/or soft tissue swelling.
Individuals with hand OA can be divided into differ ent subgroups depending on the joints in the hands that are affected; these subgroups consist of nodal OA, first CMCJ OA and another presentation called erosive hand OA, in which the subchondral bone is affected by cen tral erosions. First CMCJ OA is thought to occur most frequently, followed by nodal IPJ OA, a nonnodal form of IPJ OA and erosive hand OA 5 . However, apart from first CMCJ OA, which frequently occurs in isolation, there is considerable overlap in presentations among these subgroups, suggesting shared aetiologies 5 .
First CMCJ OA. Patients with first CMCJ OA have increased pain sensitivity, a reduced range of motion in thumb abduction and a decreased combined thumb abduction and index finger extension strength com pared with healthy individuals 31 . Notable associations between selfreported pain and function have been reported for these patients. Furthermore, compared with healthy individuals, patients with this condition have reduced grip and pinch strength 32 , including a decrease in cylindrical grasp and key pinch strength that can begin in the early stages of disease 33, 34 . Some of these presentations might be due to changes in the structure and composition of the joint and changes in the innervation of the dorsal radial ligament, which has an important proprioceptive and stabilizing role for the thumb base 35 . In individuals with symptomatic first CMCJ OA, the presence of both ligament rup tures and dorsal subluxation is a common finding on MRI 36, 37 . The grind test (where the examiner exerts pressure while rotating the joint to test whether pain or crepitus are elicited) has frequently been used to deter mine the presence of first CMCJ OA 38 . However, in a 2014 study, the tractionshift (subluxationrelocation) test (where the examiner provokes subluxation and relocation of the joint passively to test whether pain is elicited) had higher sensitivity, specificity and positive and negative predictive values for first CMCJ OA than the grind test 39 .
Key points
• Hand osteoarthritis (oA) is highly prevalent, and individuals with this condition frequently report symptoms of pain, functional limitations and frustration in undertaking everyday activities.
• Clinical imaging is not recommended for the diagnosis or routine monitoring of patients with hand oA unless an alternative diagnosis is suspected.
• mrI and ultrasonography findings have provided insight into hand oA pathology, but further prospective studies are required to inform on how features of the disease change over time.
• Hand oA is multifactorial in aetiology with evidence for the involvement of abnormal mechanical loading and hereditary factors, whereas the contribution of inflammation to pathogenesis remains contentious.
• recommendations for core treatments in the management of hand oA should be integrated into clinical practice to improve the quality of care for patients.
• A greater understanding of the presentation, pathogenesis and disease course is needed to help provide targeted therapy with existing and new treatments.
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Nodal OA. Nodes are the hallmark of nodal OA and most frequently affect the DIPJs (Heberden nodes), followed by the thumb IPJs and the PIPJs (Bouchard nodes). The pattern of joints affected by nodes is sim ilar to the pattern of joints affected by radiographic features 40 , but although the presence of nodes is asso ciated with underlying radiographic OA, IPJ OA can present with tenderness and bony enlargement without nodal involvement 41 . Nodal OA occurs more often in women than in men and occurs most often in the dominant hand, suggesting the involvement of mechanical and hormonal factors 40 . Patients with nodal OA frequently have synovitis, osteophytes, carti lage loss and central and marginal erosions 42 ; aesthetic discomfort is also common 43 . A strong positive associ ation between the presence of nodes and radiographic OA (in particular, the occurrence of JSN) supports the notion that a clinical observation of nodes can be taken as an indication of hand OA without the need for radiographic assessment 40 .
Erosive hand OA. The predominant features of ero sive hand OA are central erosions and collapse of the subchondral bone. The term erosive OA is arguably a misnomer, as central erosions are evident in many patients to some degree depending on the imaging modality used 44, 45 ; hence, this condition probably repre sents an extreme phenotype of these changes. Although erosive hand OA is commonly considered a separate dis ease, increasing evidence suggest that this condition is a severe form of hand OA 42, 46, 47 . Erosive hand OA can affect the first CMCJ as well as the IPJs, but patients rarely have erosive OA of both the first CMCJ and the IPJs (most patients have central erosions exclusively in one or the other) 48 . Erosive OA of the IPJ occurs predominantly in women, whereas erosive OA of the first CMCJ occurs more often in men than in women 48 . Erosive hand OA has a higher clinical burden than nonerosive forms of hand OA, and the associated disability might be as severe as that associated with rheumatoid arthritis (RA), depending on the setting 49, 50 . Inflammatory changes, including synovitis and ten osynovitis (determined clinically as soft tissue swelling and by ultrasonography) and effusions and central and marginal erosions (determined by MRI), are frequently observed in patients with either erosive hand OA or nodal OA 42 . The frequency and patterns of joints affected by erosive disease and severe nonerosive forms of hand OA are similar 46, 47 . However, progression of synovitis, joint effusion and radiographic OA occurs more frequently in patients with erosive hand OA than in patients with nonerosive forms of hand OA (inde pendently of the amount of synovitis and radiographic structural damage present at baseline) 51, 52 . Furthermore, the findings of a 2016 study indicated that patients with erosive hand OA had a higher level of inflammation (including a higher power Doppler activity, which is an indicator of the level of vascularization) than patients with nonerosive hand OA, suggesting that the inflam matory phenotype differs in erosive and nonerosive forms of hand OA 52 . This concept requires further investigation.
Individual and societal burden
The presence of hand OA frequently affects the abil ity of an individual to undertake everyday activi ties 53, 54 . Symptomatic hand OA is associated with poor selfreported general health, although the strength of this association varies by country and is often partially mediated by impaired physical hand function 55 . In a number of studies, the presence of hand OA and pain related to hand OA has been associated with atheroscle rosis and cardiovascular disease [56] [57] [58] [59] [60] . This association is analogous to the increased cardiovascular mortality observed in patients with painful OA of the large joints compared with the general population 61 ; this increased nATure revIeWS | RheumATOlOgy mortality is assumed to be caused by decreased loadbearing exercises, but the association with hand OA suggests the involvement of other factors. Conversely, some data from the past 3 years would indicate that indi viduals with hand OA have a similar risk of allcause and cardiovascular diseasespecific mortality to the general population 61, 62 . Patients with hand OA are frequently dissatisfied with the appearance of their hands, especially patients with Heberden and Bouchard nodes, joint deformity and/or erosive hand OA 43 . Aesthetic dissatisfaction has negative effects on the patient symptoms, including increasing the level of pain and stiffness and decreasing the function of the hand; aesthetic dissatisfaction is also associated with depression, anxiety and negative percep tions by the patients about their illness 43, 63, 64 . Patients with hand OA can have a distorted mental representation of pain in the hand, and normalization of this distortion by multisensory illusions might offer pain relief 65 . Although much is known about the economic burden of hand OA in terms of the direct costs of some treat ments, less is known about the indirect costs of this con dition such as loss of productivity [66] [67] [68] . For example, in one study, arthroplasty surgery for first CMCJ OA often resulted in substantial time off work 69 . Further research is required in this area.
Imaging
Radiography
For decades, radiography has been used to determine the presence and severity of hand OA and to examine dis ease progression in both clinical and research settings, including in randomized controlled trials (RCTs) 70, 71 . This technology is widely available, inexpensive and is an acceptable procedure to patients. However, the inability to view nonbony structures (such as the joint capsule, synovium, ligaments and tendons and their entheseal attachment to the bone) using radiography and the insensitivity of this technique in detecting struc tural pathology limit its utility in both settings compared with other imaging modalities. For these reasons, and as hand OA can often be reliably diagnosed on the basis of clinical presentations, EULAR and the National Institute for Health and Care Excellence (NICE) do not recom mend imaging for the routine diagnosis of hand OA 8, 72 , although imaging might be useful in excluding other conditions 72, 73 . Routine imaging is not recommended for clinical monitoring unless there is an unexpected and .) Radiography still has a place in the research setting; however, which scoring methods to use are still debated and might depend on the objective of the study and the population studied (for example, patients with erosive versus patients with nonerosive forms of hand OA) 74, 75 . Although radiography might have a low sensitivity in detecting features in early disease, the ability of this technique to detect hand OA progression over 5 years is similar to that of 1.0 Tesla MRI, although these imag ing modalities do not always detect progression in the same joints 76 . Given that the cost of radiography is lower than that of MRI, radiography is the suggested imaging modality of choice in observational studies with a long followup period 76 .
Advances in ultrasonography and MRI
In the past 10 years, the use of ultrasonography and MRI for assessing patients with hand OA has increased, providing greater insight into the pathology of the disease and increased evidence that these imaging modali ties have a higher sensitivity than radiography in determining the presence of pathological features such as osteophytes, JSN and central erosions 47, [77] [78] [79] [80] [81] . Using ultrasonography and MRI, researchers have shown that inflammatory changes in the synovium and at the enthesis of the hands are a common finding in hand OA 30, 82, 83 . Bone marrow lesions (BMLs) are also detect able in the hands by MRI (consistent with other joints affected by OA) 30, 84 . Ultrasonography enables realtime multiplanar imag ing at a relatively low cost. With this approach, inflam matory and structural changes can be observed without the use of ionizing radiation or the need for a contrast agent; however, this technique is operatordependent, and bony structures such as cysts and BMLs cannot be detected. Several ultrasonography scoring systems for hand OA have been developed for grading pathologi cal features as well as for use in research studies 80, 85, 86 . On the basis of interobserver and interreliability scores, the Outcome Measures in Rheumatology (OMERACT) group has endorsed the scoring of osteophytes using the Mathiessen atlas 13, 80 . However, although ultrasonogra phy is reliable for determining healthy cartilage or a total loss of cartilage, the use of the ultrasonographic atlas for grading the severity of cartilage pathology is not sup ported 13 . Ultrasonography findings have good concord ance with MRI findings 42, 87 , but the associations between ultrasonography findings and symptoms have differed across various studies 36, 82, 83, 88, 89 . Although MRI is more expensive and takes a longer time to scan patients than other imaging modalities, this imaging modality is important in OA research (includ ing in clinical trials), as it enables the visualization of all joint structures through different pulse sequences in multiple planes 90 . The Oslo hand OA MRI scoring system includes assessments of osteophytes, JSN, cen tral erosions, cysts, BMLs, malalignment, collateral ligament pathology, synovitis and flexor tenosynovitis in the DIPJs and PIPJs
91
. This scoring system has good intrarater and interrater reliability, has good construct validity (in relation to joint tenderness) and has higher sensitivity in determining the presence of osteophytes and erosions than radiography, CT or ultrasonography; however, this approach is time consuming because of the number of features and sites that require exam ination 81, [91] [92] [93] . In patients with erosive hand OA, the presence of synovitis and BMLs has been assessed by the Oslo hand OA MRI scoring system, and has shown good intrarater and interrater reliability and is asso ciated with clinical symptoms, demonstrating good construct validity 94 . The Oslo hand OA MRI scoring system has been refined, and the updated version, referred to as the HOAMRIS scoring system, includes measurements of the volume and extent of damage to the joint surface (to enable an improved assessment of central erosions compared with the Oslo hand MRI scoring system), excludes the assessment of collateral ligament pathology and flexor tenosynovitis and combines the assessments of the proximal and the distal joint surfaces (which were graded separately for the Oslo scoring system) for grad ing central erosions, cysts and BMLs
95
. The HOAMRIS scoring system has good interreader reliability for crosssectional readings but has lower longitudinal reli ability, which is thought to be because of the small range of change scores for many of the features. The respon siveness of this scoring system to change (as assessed by the standardized response means) at the patient level (that is, the sum scores for all DIPJs and PIPJs) is good for all assessed features, except for cysts and BMLs synovitis, BMLs and JSN predict radiographic progres sion in hand OA over 2 and 5 years 98, 99 . Baseline and persistent ultrasonography features including synovi tis, joint effusion and power Doppler ultrasonographic activity in hand joints are associated with radiographic progression in the same joints after 2 and 5 years 100, 101 .
Researchers have used ultrasonography to measure the treatment response of individuals with hand OA after intramuscular and intraarticular injections of steroid or other agents 36, 102, 103 .
Developments in CT
CT enables more detailed visualization of the bone structures than radiography, MRI or ultrasonography (although this approach requires a high dose of ionizing radiation); hence, in the past few years, this technol ogy has been used for research purposes in hand OA. By using highresolution peripheral quantitative CT (HRpQCT), a technique that is based on CT but is able to achieve higher resolution images over a smaller field of view, researchers could show that new bone forma tion is more common at the cartilage-bone interface and joint margins in hand OA than in PsA 105 . Additionally, diseaseassociated bone formation is located predom inately on the palmar and dorsal sites in hand OA, whereas PsA has more widespread involvement, suggest ing that different mechanisms of aberrant bone forma tion occur in these two conditions 105 . Findings from 3D CT imaging show that the curvature of the trapezial and first metacarpal articular surface of patients with early CMCJ OA differs from that of younger or older healthy individuals 106 . Additionally, using MicroCT (radio graphic imaging in 3D on a small scale), researchers have identified differences in the structure and configuration of the trapezium trabecular bone in individuals with and without first CMCJ OA 107 . These findings indicate that morphological changes of the bones and joints can occur at the thumb base in hand OA.
Novel imaging methods in development
Following the advancement of laser technology, several optical imaging modalities have been developed that might be applicable to hand OA 108 (Box 2), including dif fuse optical tomography, fluorescence optical imaging and optical coherence tomography as well as related techniques such as photoacoustic imaging. These tech niques offer lowrisk (nonionizing radiation) imaging, differentiation between the soft tissues in the hand and fast processing times 108 . To date, these techniques have been predominantly used for in vitro and ex vivo appli cations, whereas their use in vivo, particularly in patients with hand OA, is limited and is still undergoing develop ment and testing 109 . The use of systemic contrast agents for some of these applications might limit their use and acceptability to patients.
Symptoms and structural pathology
Discordance or weak associations between clinical symptoms and radiographic structural changes are frequently reported in OA, and hand OA is no excep tion 110 . However, it is possible that imaging modali ties that are more sensitive than those currently in use could reveal stronger associations. In a 2015 systematic review of various crosssectional studies, the research ers concluded that MRIdefined BMLs, osteophytes, bone attrition and cysts were not associated with hand pain severity 111 . However, various MRIdefined features (such as moderate or severe synovitis, BMLs, central ero sions, cartilage attrition and osteophytes), in addition to various ultrasonographydetermined features (such as osteophytes, synovitis and the absence of joint carti lage), have been associated with tenderness in the same joints 79, 92, 110 . Furthermore, the cumulative effects of OA in multiple hand joints is associated with more severe hand pain 112 , functional limitation 92 and weaker grip and pinch strength 18, 92, 113 . Little is known about the course of symptoms in hand OA over time and how they relate to structural pathology. Inflammation (as determined by ultrasonography) has been associated with the pro gression of radiographic hand OA and the subsequent development of bone erosions 114, 115 ; however, further longitudinal research will enable a better understating of the disease processes and could help identify potential targets for treatment.
Disease mechanisms
Studying the pathogenesis of hand OA is difficult: researchers have limited access to diseased tissue, and for tissue that is available, the quantities obtained for molec ular analysis are small. Healthy donor tissue (to use as a control) is rarely available, and no animal models of hand OA exist. In addition to the epidemiological and in depth prospective imaging studies detailed above, our understanding of hand OA disease pathways comes from a combination of genetic data analysis and the outcomes (positive or negative) of clinical studies.
An important question to address is whether hand OA shares similar pathogenic pathways with OA at other joint sites. Of the common aetiological factors, perhaps the most important factor is abnormal mechanical loading. Although the joints of the hands are not weight bearing, they are nonetheless load bearing. Evidence for the involvement of mechanical loading in the develop ment of hand OA is best demonstrated by the higher prevalence of OA in the dominant hand than in the nondominant hand (80% of righthanded individuals with hand OA are predominately affected in their right hand) 116 and the lack of disease in the immobilized hand (for example, owing to hemiparesis or polio) of some patients with OA of the other hand 117, 118 . Inflammatory changes in the entheses of the interphalangeal joints of patients with hand OA suggest that this tissue is an important area of stress 119 . Several features are unique to hand OA. For instance, unlike OA of the large joints, the incidence of hand OA peaks around the time of meno pause 27 , the early inflammatory phase of disease seems to predate bone remodelling, and joint tenderness often seems to improve in individuals over time (T.L.V., unpublished observations).
Genetics of hand OA
Genetic studies can provide powerful insights into pathogenesis. Hand OA has the highest estimated heri tability of all types of OA (approximately 60%) 120 . A comprehensive review published in 2008 summari zed all genetic studies in hand, hip, knee and spine OA, drawing from the literature published up until 2006 121 . This study revealed just two candidate gene associations that had been replicated for hand OA: genetic variants in ACAN (encoding aggrecan, an integral component of the extracellular matrix in cartilaginous tissue) and HFE (encoding homeostatic iron regulator, a protein associated with haemochromatosis) 121 . Since this study, five genomewide association studies (GWASs) [122] [123] [124] [125] [126] and numerous candidate gene studies have been published. For convenience, gene candidates can be grouped into three areas according to their putative role in disease (Fig. 2) : those that are associated with growth factor signalling 123, 124, [127] [128] [129] [130] , those that contrib ute to the integrity and calcification of the extracellular matrix of cartilage 122, 125, [131] [132] [133] [134] [135] and those that relate to inflammatory pathways 126, [136] [137] [138] [139] [140] . Two GWASs in hand OA deserve further attention. The first was a study in Iceland in which two loci were identified: one on chro mosome 1, a rare variant associated with severe hand OA (no further allelic characterization was given), and a second common set of variants on chromosome 15, all in ALDH1A2 (reF.
126
). ALDH1A2 encodes the enzyme retinal dehydrogenase 2 (ALDH1A2), which catalyses the synthesis of cellular retinoic acid. The polymor phic variants in ALDH1A2 are hypomorphic (that is, associated with lower levels of ALDH1A2 in hand OA cartilage) 141 . Retinoic acid is essential for forelimb development in the embryo and is a potentially inter esting target, as this metabolite has antiinflammatory effects on many different cell types including chon drocytes 142 . Paradoxically, chondrocyte biologists use retinoic acid to stimulate cartilage catabolism (albeit at supraphysiological levels) 143 .
Box 2 |
Novel and alternative imaging methods in development applicable to hand OA
Diffuse optical tomography and photoacoustic imaging
In diffuse optical tomography (DoT), light from the near-infrared spectral region is passed through tissues, and the spatial and temporal variation in light absorption and scattering is measured and used to construct tomographic images 230 . using 3D DoT, researchers could distinguish between distal interphalangeal joints affected by osteoarthritis (oA) and healthy joints 231 . After further methodological refinements, this technique could distinguish between patients with hand oA and patients with psoriatic arthritis or healthy individuals 232 . Incorporating photoacoustic imaging with DoT improves the image resolution, enabling better differentiation of bone from soft tissue 233 .
Fluorescence optical imaging
In fluorescence optical imaging (FoI), tissues are illuminated with a light source that can range from ultraviolet to infrared; this light excites fluorophores that have been introduced through a fluorescence contrast media that accumulates at sites of inflammation 234, 235 . In one study investigating the use of FoI in oA, which looked at joints of the hand, the researchers noted that although similar proportions of individuals with inflammation were distinguished using FoI and grey-scale or power Doppler ultrasonography in patients with either oA or rheumatoid arthritis, a particular phase of fluorescent dye flooding in (phase 2) FOI might be more informative in oA 236 .
Optical coherence tomography optical coherence tomography (oCT) employs light from the infrared end of the spectrum, which is passed through the tissues under investigation; the resulting reflections are measured, and cross-sectional images are produced. oCT can be used to visualize cartilage in the first carpometacarpal joint and to detect early changes including thickening of the cartilage and changes to the articular surface that are consistent with histology findings 237 . Additionally, overlaying the OCT images onto CT images can help with the visualization of cartilage 237 .
Trabecular bone texture
The texture of trabecular bone is quantifiable, and changes in bone texture are observable in early oA at the knee 238, 239 . Work using directional fractal signals has now extended this finding to the smaller regions of the hands, and the use of augmented variance orientation transform (AVOT) has the potential to be useful in the early detection and prediction of hand oA 240 .
Positron emission mammography
Positron emission mammography (Pem) is a nuclear medicine modality that has been used to detect or characterize breast cancer. The PEM scanner has a small field of view but is comparable to a standard PET or CT scan for evaluating hand oA 241 .
Photography
A system for scoring hand oA from photographs offers an alternative method of diagnosing hand oA to clinical or radiographic assessment and is a commonly used, reliable and valid method of scoring hand oA 242, 243 . It offers researchers a feasible alternative method of data collection, which might be of particular use for large population-based studies or studies covering wide geographic or remote areas. volume 
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The second study, a 2017 GWAS from the Netherlands, identified a locus on chromosome 12, close to MGP 125 . This gene, also identified in a previous candidate gene study 133 , encodes matrix Gla protein (MGP), which is responsible for preventing calcification of cartilage; the hypomorphic function associated with the risk variant might predispose individuals to abnormal chondrocal cinosis and altered biomechanical properties of the car tilage. MGP is known to be regulated by transforming growth factorβ (TGFβ), and so it is of interest that can didate gene studies from the past few years have added further support for the association of hand OA with poly morphic variants in genes encoding TGFβ family mem bers 131, 132, 136 . These associations are consistent with the purported chondroprotective role of TGFβ in the joint.
Sex hormones and hand OA
All types of OA have a higher prevalence in postmeno pausal women than in premenopausal women, but the relationship that hand OA has with the typical time of menopause onset seems to be unique and robust 27, 144 . For instance, perimenopausal symptoms (such as hot flushes and irregular menstrual cycles) commonly occur at the time of presentation with hand OA 144 . Whether this relationship is due to the loss of the established antiinflammatory and proreparative effects of oestro gen or related to fluctuations in other sex hormones is currently unclear. Both oestrogen and testosterone reg ulate the expression of ALDH1A family members 145 , and it is tempting to speculate that there might be important crosstalk between retinoic acid and oestrogen signalling in the perimenopausal period.
Inflammation and hand OA
The role of inflammation in hand OA remains par ticularly contentious. Although it is widely accepted that inflammatory changes (including clinical and imagingbased synovitis) occur in disease, these changes are typically relatively modest in hand OA compared with inflammatory arthritides such as RA 146 , and the pathogenic role of inflammation is far from certain. Data from prospective imaging studies show that baseline syn ovitis on MRI or ultrasonography predicts radiographic progression or central erosion, respectively 99, 114, 115, 147 However, it is worth bearing in mind that the presence of BMLs and JSN also predicts progressive disease 99 , and so it is possible that inflammation is a consequence rather than a cause of progressive disease.
A wide range of OA serum or plasma biomarkers have been investigated in hand OA, which can pro vide insight into disease development. These biomark ers include various inflammatory markers, such as Creactive protein and adipokines, and markers of car tilage or bone homeostasis, such as type II collagen 148, 149 . In one small substudy of 18 patients from a 2016 hand OA clinical trial, serum IL1 levels were associated with loss of hand function and radiological erosions 150 . Although this study raises the possibility that erosive and nonerosive OA have different biomarker profiles, to date, biomarker characterization remains less devel oped for hand OA than it is for OA at other sites such as the knee. Currently, there are no validated serum or plasma biomarkers for diagnosing hand OA, stratifying its severity or predicting its progression or response to treatment.
Results from clinical trials can also aid in the under standing of disease pathogenesis. Intraarticular steroid therapy is routinely used in many cases to treat sympto matic hand OA. A 2015 RCT of 60 patients with symp tomatic hand OA showed that steroid (triamcinolone) injection in combination with lidocaine (a local anaes thetic) resulted in a statistically significant improvement in the patients' hands in terms of pain on movement and physician's assessment of swelling compared with treat ment with lidocaine alone 151 . Interestingly, lidocaine injection alone resulted in a striking response in the patients in this study, and five secondary disease activ ity measures did not differ between the two groups. The emphasis on targeting inflammation in hand OA has been further unsettled by the negative results of several RCTs in hand OA using traditional antiinflammatory or 'antisynovial' agents. These findings include a failure to demonstrate a difference between placebo treatment and treatment with hydroxychloroquine 152, 153 , antiTNF agents 154, 155 or IL1targeting strategies 156 .
Advances in therapy
The management of hand OA combines both nonpharmacological and pharmacological approaches. Surgical treatments are offered to those with severe symptoms and for whom conservative approaches have failed 29 . In this section, we describe findings from orig inal studies produced within the past 5 years for core reco mmendations (a range of selfmanagement support), firstline analgesia and novel pharmacological targets.
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Fig. 2 | Predicted molecular drivers of hand osteoarthritis by genetic association.
Mechanical load is central to the pathogenesis of hand osteoarthritis (OA) and influences growth factor bioavailability , inflammation and matrix degradation.
The genes shown in this figure have been linked to radiographic or symptomatic hand OA in at least one study (some of which have not been replicated). ERK; extracellularsignal-regulated kinase; PI3K , phosphoinositide 3-kinase.
a Genetic associations that were identified by genome-wide scans (the other associations were identified using candidate gene approaches).
Non-pharmacological therapies
In a 2017 systemic review, Lue and colleagues 157 pro vided an update on an earlier review 158 of nonsurgical therapies for hand OA, and the reader is directed to this manuscript for an appraisal of the quality of some of the studies discussed below. In this section, a summary of the core and adjunctive treatments and surgery are briefly provided.
Core interventions: self-management support. Selfmanagement programmes for hand OA can include a range of approaches such as providing the patient with written information on hand OA and selfmanagement approaches, giving advice on hand exercises and joint education (such as joint protection strategies and pacing of activities), weight management strategies and using new models of care 159, 160 . For example, Moe et al. 160 con cluded that the use of an integrated, multidisciplinary care model, although not superior in clinical outcomes, resulted in greater patientreported satisfaction than usual care.
Written information on the underlying disease and selfmanagement approaches, such as the OA guide book 161 , are essential components of the core manage ment of hand OA, although limited evidence is available for the effectiveness of hand OA education alone. In the trial that tested an OA consultation model (which con sisted of an OA guidebook, an OA consultation with a general practitioner and a subsequent followup with a practice nurse in a dedicated OA clinic), the supply of written information by general practitioners and prac tice nurses to patients increased from 4% to 28% in the model OA consultation arm, whereas no changes from baseline were observed in the control arm (which con sisted of usual care alongside a resource pack of writ ten advice for patients) 162 . Although implementation of this model did not improve the health status of patients, it did improve the implementation of clinical guide lines (the NICE OA recommendations) by clinicians and allied health professionals, along with the use of selfmanagement approaches 159 . Education on maintaining joint health is often described as 'joint protection education' or 'joint education' . In the SMOOTH (SelfManagement of Osteoarthritis of the Hand) study, which included communitydwelling adults (aged 50 years and over) with ACRdefined hand OA, the individuals who attended occupational therapy classes for joint protection educa tion (using written patient information from an Arthritis Research UK booklet 163 ) were twice as likely to respond to treatment than those who did not attend the classes 164 . Several trials of hand exercise for hand OA [165] [166] [167] have been published in the past few years, along with a Cochrane systematic review 168 . Exercise is recognized as an effective analgesic therapy for those with OA at any site 169 . However, despite continued efforts to iden tify the specific benefits of exercises for hand OA, the Cochrane review 168 found that the magnitude of the benefit of exercise and which exercises should be prescribed are still uncertain. For complex interventions, blinding the therapist or patient to the intervention is difficult, and in large studies, selfreport questionnaires are often used, which contribute to a low quality rating of the study when assessed in systematic reviews. The findings suggest that recommending one approach to exercise over another is not possible at present for hand OA. Few studies have investigated the costeffectiveness of exercise in the management of hand OA, but findings from the SMOOTH study show that hand exercises, delivered in classes by occupational therapists, could be a costeffective approach over 12 months 66 . The association of obesity and hand OA is contin ually debated 170, 171 . Weight management forms part of a holistic approach to managing OA in general, and as hand OA often coexists with OA in other sites, consul tations for hand OA provide an opportunity to offer weight management advice and referral to services if a patient is overweight, as recommended by NICE quality standards 8, 9 .
Adjunctive conservative therapies. Several systematic reviews have been published in the past few years on the use of nonsurgical treatments for first CMCJ OA 172, 173 . Local treatments such as splints (prefabricated or cus tom orthotics worn on the affected joint) might offer warmth, support and stabilization of joints that are normally painful on movement. However, there con tinues to be uncertainty about the exact mechanism of action of splints and regarding their optimal design and instructions for use to maximize adherence and safety. Soft splints, off the shelf splints and splints worn at nighttime might be more acceptable to patients than hard splints, custom made splints or splints to be worn during the day [174] [175] [176] . Researchers have investigated splints or orthoses for first CMCJ OA [177] [178] [179] [180] [181] and IPJ OA 157, 172, 173, 182 as well as pressure gloves for hand arthritis 183 . However, currently, what type of splint is best is unclear, and data are incon sistent as to whether splints provide symptom relief in the hand 157 . The use of splints does improve function and pinch strength in patients with first CMCJ OA 172, 173 . Most studies of splinting have a high risk of bias because of difficulties in establishing or maintaining participant blinding or including true sham devices, but the inclu sion of a placebo splint in new upcoming studies such as the OTTER (OA of the Thumb Therapy) trial gives an opportunity to address some of the key limitations of previous trials of splinting [174] [175] [176] .
Other non-pharmacological therapies. Several other therapies that have been tested for the treatment of hand OA include spa therapy 184 , joint mobilization 185 , taping 186 and ultrasound therapy 187 . Although evidence is limited for the efficacy of such treatments, these approaches have been recommended in various clinical guidelines for the management of hand OA such as the EULAR Hand OA recommendations 29, 188, 189 . compared with oral paracatamol 190 and placebo 191 ). Overall, topical NSAIDs are superior to placebo for relieving pain and improving function in OA 191 . Although salicylate gel is associated with higher with drawal rates owing to adverse events, the remaining topical NSAIDs are not associated with any increased local or systemic adverse events 191 . The benefits of top ical NSAIDs have been summarized elsewhere 192 , but there is still uncertainty over the relative efficacy of top ical NSAIDs compared with the efficacy of other topical treatments such as capsaicin.
Pharmacological therapies
Topical capsaicin, an extract of hot chilli pepper, is recommended for the treatment of OA pain 8 , but studies of this treatment in hand OA are limited. In a 2014 systematic review 193 of RCTs of topical capsaicin use in OA, which included five doubleblind RCTs and one casecrossover trial, only one study included patients with hand OA. Capsaicin was reported to be safe and well tolerated across all the included studies, with no evidence of systemic toxicity 193 . This treatment is associated with mild burning at the application site, which peaks after 1 week and declines over time 193 . Capsaicin might therefore be more suited to patients who lack inflammatory signs and have persistent pain or neuropathic symptoms, which aligns with the use of capsaicin for neuropathic pain associated with other conditions. Capsaicin treatment efficacy warrants further investigation. Local analgesia. Injecting drugs such as glucocorticoids directly into the joints provides local symptomatic relief and offers another option in addition to core treatment. Interest in the use of intraarticular injection therapy in hand OA continues 151, [194] [195] [196] [197] [198] , as this approach is pref erable to surgical approaches in elderly patients with comorbidities 198 . The benefits and harms of intraarticular therapies were assessed in a 2016 systematic literature review and metaanalysis; this analysis included trials that investigated the efficacy or safety of any intraarticular therapy in first CMCJ and IPJ OA compared with placebo or other treatments for which pain was the main outcome 198 . A total of 13 trials (including 864 patients with hand OA, 11 trials of patients with OA of the first CMCJ and 2 trials of patients with OA of the IPJs) were included. The results of a metaanalysis of two trials comparing intraarticular corticosteroids and placebo treatment in patients with first CMCJ OA indicated that intraarticular corticosteroids resulted in no improvement in pain. Synthetic hyaluronan also seemed inefficacious compared with placebo in patients with first CMCJ OA. However, in one trial of patients with OA of the IPJs, the patients receiving corticosteroids had considerable improvements in pain during movement compared with the patients receiving placebo 151 . The authors of the systematic review 198 con cluded that intraarticular injection of corticosteroids or hyaluronan do not seem more effective than pla cebo in first CMCJ OA. However, the placebo response can be large, and intraarticular use in combination with other modalities such as splinting might still be a relevant option.
Adjunctive analgesia. Paracetamol is prescribed for hand OA if topical treatments are ineffective or not tol erated 8 , although the effect size of this therapy in the treatment of large joint OA might be smaller than pre viously thought 190 . If ineffective, and following careful assessment of the risks and benefits to the individual, oral NSAIDs (such as naproxen), cyclooxygenase 2 (COX2; also known as PTGS2) inhibitors or opiates might be introduced. These drugs should generally be used sparingly and only when required to limit the risk of toxicity. A proton pump inhibitor should be prescribed along with NSAIDs to protect against NSAIDinduced gastrointestinal adverse events 199 . In a 2015 study of patients with first CMCJ OA 200 , in the small number of participants included in the final anal ysis (n = 19), the patients receiving naproxen had a con siderable reduction in brain activity in areas commonly associated with pain perception compared with those patients receiving placebo.
The use of several novel agents has been investigated for the treatment of hand OA and typically involves the repurposing of diseasemodifying antirheumatic drugs or biologic therapies licensed for use in RA: these therapies include adalimumab, a monoclonal antibody to TNF 154 , hydroxychloroquine 153 , doxycycline 201 and GCSB5, a herb extract 202 . Evidence from these stud ies suggests that adalimumab and hydroxychloro quine are not effective in treating hand OA pain 153, 154 . Further studies are needed to identify oral treatments that improve hand pain or modify the course of dis ease. Several drug trials in OA, including ongoing trials, might be relevant to hand OA and have been reviewed elsewhere 203 . The ongoing clinical trials include drugs that inhibit inflammatory mechanisms (such as GMCSF 204 and antiIL6 (reF.
205 )), but novel targets relevant to other OA mechanisms might be needed to move the field forward.
Nutraceuticals are not recommended by NICE for the management of OA, but researchers have investigated their effects in hand OA. In a systematic review of oral chondroitin for OA, including hand OA, chondroitin treatment (alone or in combination with glucosamine) was associated with a shortterm benefit in terms of pain relief compared with placebo (although most of the stud ies assessed were of low quality) 206 . The low risks associ ated with chondroitin might account for its popularity as an overthecounter supplement in individuals with hand OA, but more evidence is needed to advocate the use of this supplement in routine clinical practice.
Surgery. Surgery in hand OA is recommended for patients who are refractory to nonsurgical manage ment 8 . In a survey of 163 patients with first CMCJ OA, the results confirmed that patients predominantly visit hand surgeons seeking treatment to reduce pain and that improvements in function and aesthetic image are a lower priority for these patients 207 . The findings highlight the need to elicit patients' expectations before treatment and to discuss potential treatment outcomes in order to achieve optimal gain from surgery. Placebocontrolled RCTs for many surgical procedures carried out for the treatment of hand OA are lacking.
Guidelines and implementation
Guidelines have previously been published that address the clinical management of hand OA 8, 29, 208, 209 , includ ing the newly released 2018 update from EULAR 188 . However, ensuring the uptake of guidelines in clinical practice is challenging 159, 162 . Improvements are needed in the ways of recording hand OA diagnosis in primary care and evaluating the quality of hand OA care, includ ing the implementation of guidelines. Demonstrating an association between the implementation of clinical guidelines and improvements in the health status and function of patients is difficult in real world settings 159 . This field of investigation is growing; for example, ways in which to measure the quality of care that include valid quality indicators and demonstrate the effects of implementation are now high on the research agenda.
Regarding research guidelines, a preliminary core set of outcomes has been developed by OMERACT using Delphi exercises and systematic literature review 210 . In clinical trials of symptom modification, the minimum outcomes should include assessments of pain, physical function, joint activity and hand strength as well as global patient assessment. For clinical trials examining structure modification as well as observational studies, structural damage should also be examined 210 . Finally, guidelines on imaging in hand OA clinical trials are also available 71 .
Conclusion
Hand OA is a common, disabling, heterogeneous con dition. Studies in the past few years have provided some advances in our understanding of the burden and underlying mechanisms of hand OA as well as regarding hand OA therapy, but there is much still to understand. Localized therapies for hand OA such as hand exercises and topical treatments offer small but clinically important amounts of symptomatic relief in hand OA and should arguably be more widely used. Hydroxychloroquine, previously used anecdotally off label to treat severe forms of the disease, is now known to be ineffective in the treatment of established symptomatic radiographic hand OA and should not be used in such patients. The lack of efficacy of many antirheumatic drugs in hand OA has catalysed a reevaluation of potential disease targets. The dis appointing results from clinical trials reaffirm the need for a better understanding of basic underlying disease mechanisms, and arguably a better method for identifying and stratifying patients with early dis ease and/or who are at high risk of progression, at a time when disease processes might be susceptible to intervention.
In primary care management, the diagnosis of hand OA without the use of imaging is still recommended by international guidelines 8 . A better approach for classify ing and coding the disease is needed. Such an approach is essential for improving the delivery of quality care for this common condition. Guidelines such as the newly updated 2018 EULAR recommendations 188 for the man agement of hand OA will continue to improve the quality of care for patients with hand OA, provided that steps are taken to accelerate the implementation of such guidance into every day practice.
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